Drivers warned to act now as DVLA plans to ‘modernise' driving system
DVLA plans to introduce digital vehicle tax services which will 'modernise' the British driving system.
This will allow motorists to renew their car tax without needing a log book or paper reminder letter.
Read more: PIP claimants warned they 'face a two-tier benefits system'
The upgrade is part of the DVLA's push to modernise services, meaning drivers can now tax their vehicles online even if they've lost their V5C log book or haven't received their V11 tax reminder in the post.
Failing to keep your vehicle taxed could land you with a fine of up to £1,000, with enforcement cameras able to catch untaxed cars instantly.
However, with millions of drivers set to hit the roads for summer holidays and festivals, experts warn that a missed renewal could ruin travel plans or lead to unexpected penalties.
Cherie Carter, Director at Indigo Car Hire, has four action points for new drivers to avoid unwanted penalties.
She explained: 'Firstly, it's important to log into your Driver & Vehicle Account (DVA). Make sure your email and phone number are up to date, and you should be able to receive reminders both on this topic and any other updates going forward.
'It's also important to check your personal details. One of the big reasons why so many drivers miss out on news like this is because of incorrect addresses; it could stop you from renewing online in future if you're out of date, or simply didn't update a new email or postal address.
'Verify your identity if needed: With so many security scandals of late, it's vital for both companies and users to be secure. First-time users may need to confirm their details using DVLA-approved checks.
'Finally, and this relates back to step one, but make sure you do sign up for digital reminders: Email or SMS alerts are free from the DVLA and will help you avoid fines for late renewal.
'This change is a real step forward for drivers,' Cherie continued.
She added: 'Being able to tax a vehicle online without waiting for documents will save people time and hassle.
'For car hire firms and private motorists, it's another way to keep vehicles road-legal and avoid last-minute stress.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
6 hours ago
- Indianapolis Star
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Click here to register Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Thursday, August 14, 2025, at 8:30 a.m. Eastern to review second-quarter 2025 financials and provide corporate updates. Participation Instructions for Jaguar Investor Webcast When: Thursday, August 14, 2025 at 8:30 AM Eastern Time Participant Registration & Access Link: Click Here Participation Instructions for Jaguar's Virtual Presentation at the Emerging Growth Conference When: Wednesday, August 20, 2025 from 2:55 – 3:05 PM Eastern Time Where: Online (Click Here) Registration link for conference: Click Here Replay: An archived webcast of the presentation will be made available on and on the Emerging Growth YouTube Channel. About the Jaguar Health Family of Companies Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo's crofelemer is FDA-approved under the brand name Mytesi ® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar's Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications. For more information about: Jaguar Health, visit Napo Pharmaceuticals, visit Napo Therapeutics, visit Magdalena Biosciences, visit Canalevia-CA1, visit Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram Forward-Looking Statements Certain statements in this press release constitute 'forward-looking statements.' These include statements regarding the expectation that Jaguar will file its 10-Q on August 14, 2025 for the quarter ended June 30, 2025, the expectation that Jaguar will hold an investor webcast on August 14, 2025, and Jaguar's expectation that Jaguar management will present at the August 2025 Emerging Growth Conference. In some cases, you can identify forward-looking statements by terms such as 'may,' 'will,' 'should,' 'expect,' 'plan,' 'aim,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact: hello@ Jaguar-JAGX SOURCE: Jaguar Health, Inc.
Yahoo
7 hours ago
- Yahoo
Do Wall Street Analysts Like DaVita Stock?
DaVita Inc. (DVA), headquartered in Denver, Colorado, provides kidney dialysis services to patients with chronic kidney failure. Valued at $9.3 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. Shares of this kidney care giant have underperformed the broader market over the past year. DVA has declined 8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 19.3%. In 2025, DVA stock is down 13.7%, compared to the SPX's 8.4% rise on a YTD basis. More News from Barchart This High-Yield (7%) Dividend Stock Is Down Significantly in 2025. Should You Buy the Dip? Dear CoreWeave Stock Fans, Mark Your Calendars for August 14 Tesla Is Axing Its Dojo Supercomputer Plans. What Does That Mean for TSLA Stock Here? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Narrowing the focus, DVA's underperformance looks less pronounced compared to the SPDR S&P Health Care Services ETF (XHS). The exchange-traded fund has fell about 4% over the past year. Moreover, the ETF's 1.1% gains on a YTD basis outshine the stock's double-digit losses over the same time frame. DVA's underwhelming performance can be chalked up to a notable year-over-year dip in normalized non-acquired treatment, which fell short of expectations. This downturn, coupled with a squeeze on adjusted operating margins, has put a damper on the stock's prospects. On Aug. 5, DVA reported its Q2 results, and its shares closed down more than 9% in the following trading session. Its revenue totaled $3.4 billion, up 6.1% year over year. The company's adjusted EPS came in at $2.95, up 47.5% from the previous quarter. For the current fiscal year, ending in December, analysts expect DVA's EPS to grow 12.9% to $10.93 on a diluted basis. The company's earnings surprise history is mixed. It beat the consensus estimate in three of the last four quarters while missing the forecast on another occasion. Among the eight analysts covering DVA stock, the consensus is a 'Hold.' That's based on one 'Strong Buy' rating, six 'Holds,' and one 'Moderate Sell.' The configuration has been consistent over the past three months. On Aug. 8, Truist Financial Corporation (TFC) analyst David MacDonald kept a 'Hold' rating on DVA but lowered the price target to $148, implying a potential upside of 14.7% from current levels. The mean price target of $156.57 represents a 21.3% premium to DVA's current price levels. The Street-high price target of $186 suggests an ambitious upside potential of 44.1%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
9 hours ago
- San Francisco Chronicle
Premier League chief calls for patience as Man City legal case drags on
LONDON (AP) — The Premier League's top official called for patience Wednesday while the seismic legal case involving Manchester City drags on into another season. City was charged by the league in February 2023 with more than 100 financial breaches, including providing misleading information about its sources of income. The case was heard by an independent commission between September and December last year but no verdict has been reached. Punishment could be as extreme as expulsion from the top flight. City has always denied the charges. The issue hangs over the start of another Premier League campaign, with the 2025-26 season starting Friday. But Richard Masters, the competition's chief executive, reiterated the league has no control or say over the timings. Asked in an interview with British broadcaster Sky Sports News why the league could not hurry the process along, Masters said: 'I can't answer that specific question. All I can tell you about is the system and how it works. 'I mean, it's an independent judiciary, essentially. So once the allegations, the charge, has been put forward, they go before an independent panel, which is independently selected, and they are then in charge of the process and its timings. They hear the case, they decide the outcome, and we have no influence over that, over it or its timing. That's right from an independence point of view." 'I just have to wait,' he said, "and legal processes rarely take less time than you anticipated, but we have to be patient.' Taking the Premier League abroad The Spanish league has recently approved a request for a match, between Villarreal and Barcelona, to be played in the United States in December and Masters was asked whether the Premier League had any similar desire to take a game abroad. Masters said the need has lessened. 'We did look at the '39th game' way back when, with lots of controversy. I recall that very clearly," Masters said of a controversial proposal made back in 2008 of having an extra round of matches played overseas. 'Our objective at the time, when thinking about it, was to help grow the Premier League around the world. 'And we've been able to do that through different means, through brilliant broadcast partnerships, through digital technology, investing in other areas, like the Summer Series tournament we've just had in the U.S., and now the Premier League is a genuinely global league. There are billions of people who will be tuning in over the course of the next next nine months to watch Premier League action. So we've achieved that objective by different means, that necessity has dissipated.'
